These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16447721)

  • 41. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R; Regidor C; Martín-Donaire T; Rico MA; Bautista G; Krsnik I; Forés R; Ojeda E; Sanjuán I; García-Marco JA; Navarro B; Gil S; Sánchez R; Panadero N; Gutiérrez Y; García-Berciano M; Pérez N; Millán I; Cabrera R; Fernández MN
    Cytotherapy; 2009; 11(3):278-88. PubMed ID: 19308773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Technology of bone marrow transplantation--harvest and manipulation of bone marrow cells].
    Shinohara Y
    Nihon Rinsho; 1990 Sep; 48(9):2023-7. PubMed ID: 2232206
    [No Abstract]   [Full Text] [Related]  

  • 43. Bone marrow transplantation.
    Storb R; Santos GW
    Transplant Proc; 1979 Mar; 11(1):1163-6. PubMed ID: 36699
    [No Abstract]   [Full Text] [Related]  

  • 44. Prognostic value of donor cytotoxic T-lymphocyte precursor frequencies for acute graft-versus-host disease in hematopoietic stem cell transplantation from HLA-matched siblings: a single center experience in a cohort of 92 patients.
    Sizzano F; Magistroni P; Locatelli F; Busca A; Falda M; Affaticati P; Mazzola G; Dall'omo AM; Amoroso A
    Haematologica; 2006 Mar; 91(3):397-400. PubMed ID: 16531265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hematopoietic stem cell transplantation].
    Kobayashi S; Harada M
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():717-23. PubMed ID: 11838190
    [No Abstract]   [Full Text] [Related]  

  • 47. MHC class I, II, and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation.
    Malkki M; Gooley T; Horowitz M; Petersdorf EW;
    Tissue Antigens; 2007 Apr; 69 Suppl 1():46-9. PubMed ID: 17445162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk assessment in haematopoietic stem cell transplantation: stem cell source.
    Urbano-Ispizua A
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives.
    Ringdén O; Le Blanc K
    APMIS; 2005; 113(11-12):813-30. PubMed ID: 16480452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.
    Wang Y; Chen F; Han Y; Fu ZZ; Tang XW; Miao M; Qiu HY; Jin ZM; Sun AN; Wu DP
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1258-64. PubMed ID: 19747633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.
    Kim SY; Choi HB; Yoon HY; Choi EJ; Cho B; Kim HK; Kim YJ; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Kim CC; Kim TG
    Tissue Antigens; 2007 Apr; 69 Suppl 1():114-7. PubMed ID: 17445182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bone marrow transplantation in the primary immunodeficiencies].
    Madero López L; Villa Alcázar M
    Sangre (Barc); 1999 Apr; 44(2):135-41. PubMed ID: 10382323
    [No Abstract]   [Full Text] [Related]  

  • 57. Bone marrow transplants come of age. New hope for deadly diseases.
    Meadows M
    FDA Consum; 2000; 34(4):22-7. PubMed ID: 11924631
    [No Abstract]   [Full Text] [Related]  

  • 58. Hematopoietic stem cell transplantation: 40 years of continuous progress and evolution.
    Porta F; Locatelli F; Burgio GR
    Haematologica; 2008 Nov; 93(11):1607-10. PubMed ID: 18978297
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical importance of HLA-DPB1 in haematopoietic cell transplantation.
    Shaw BE; Gooley T; Madrigal JA; Malkki M; Marsh SG; Petersdorf EW
    Tissue Antigens; 2007 Apr; 69 Suppl 1():36-41. PubMed ID: 17445160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation.
    Ho VT; Kim HT; Liney D; Milford E; Gribben J; Cutler C; Lee SJ; Antin JH; Soiffer RJ; Alyea EP
    Bone Marrow Transplant; 2006 May; 37(9):845-50. PubMed ID: 16532020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.